Raffles Medical (RFMD SP): Stellar H1 Performance Driven by Resumption of Medical Tourism
Raffles Medical’s H1 revenue grew 11%, while net profit jumped 51%. Resumption of medical tourism and returning of domestic patients seeking...
498 Views
Ramsay Health's Offer Spread Risk/Reward
At the last close, the risk/reward profile is favourable as the downside due to a deal break (-10% estimated decline) is lower than the upside...
571 Views
The Week That Was in ASEAN@Smartkarma - Philippines Election,Thai Bev, and XL Axiata
The Week That Was in ASEAN@Smartkarma is filled with an eclectic mix of differentiated, substantive, and actionable insights, macro and equity...
354 Views
Raffles Medical (RFMD SP) - Doubts About the Outlook Weigh on Bullish Sentiment
The revenue from medical tourism would just partially offset the decline of COVID-19 related revenue.RMG's revenue/earnings in FY22-23 may go...
404 Views
Raffles Medical: Earnings to Remain Under Pressure in 2022 but Long-Term Prospects Remain Attractive
We expect Raffles to be a key beneficiary of Singapore reopening, however, we expect the company’s earnings to remain under pressure in 2022E due...
405 Views